EOF Share Price History
07 Jul, 2020
ECOFIBRE LIMITED – Ananda Health products used in first FDA authorized clinical trial on hemp-derived CBD to treat chemotherapy induced peripheral neuropathy
Ecofibre Limited (Ecofibre, Company) (ASX:EOF, OTC-NASDAQ Intl Designation: EOFBF) is pleased to announce that the Lankenau Institute for Medical Research1 (LIMR) has begun patient enrollment in a Phase II clinical trial using Ananda Health hemp-derived CBD. The purpose of this study is to assess the efficacy of a hemp-based cannabidiol (CBD) product, Ananda Health Spectrum gelcaps, on the severity and duration of chemotherapy-induced peripheral neuropathy (CIPN) among breast, colon, and ovarian cancer patients who received common types of neurotoxic chemotherapy.
31 Mar, 2020
Some Ecofibre Limited (ASX:EOF) shareholders are probably rather concerned to see the share price fall 32% over the...
14 Nov, 2019
Ecofibre, Ananda Health Division - New Study Suggests CBD May Reduce or Eliminate Opioid Usage & Improve Quality of Life Measures
CYNTHIANA, Ky. , Nov. 14, 2019 /PRNewswire/ -- Ecofibre Limited (Ecofibre, Company) (ASX: EOF, OTC – Nasdaq Intl Designation: EOFBF) today announced publication of the results of an 8-week study on Hemp ...
31 Oct, 2019
Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...
02 Sep, 2019
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...